Literature DB >> 19477908

Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists.

Madhuri Ramanathan1, Wenting Luo, Balázs Csóka, György Haskó, Dmitry Lukashev, Michail V Sitkovsky, Samuel Joseph Leibovich.   

Abstract

Adenosine A(2A)R and TLR agonists synergize to induce an "angiogenic switch" in macrophages, down-regulating TNF-alpha and up-regulating VEGF expression. This switch involves transcriptional regulation of VEGF by HIF-1, transcriptional induction of HIF-1alpha by LPS (TLR4 agonist), and A(2A)R-dependent post-transcriptional regulation of HIF-1alpha stability. Murine HIF-1alpha is expressed as two mRNA isoforms: HIF-1alphaI.1 and -I.2, which contain alternative first exons and promoters. HIF-1alphaI.2 is expressed ubiquitously, and HIF-1alphaI.1 is tissue-specific. We investigated the regulation of these isoforms in macrophages by TLR4 and A(2A)R agonists. HIF-1alphaI.1 is induced strongly compared with HIF-1alphaI.2 upon costimulation with LPS and A(2A)R agonists (NECA or CGS21680). In unstimulated cells, the I.1 isoform constituted approximately 4% of HIF-1alpha transcripts; in LPS and NECA- or CGS21680-treated macrophages, this level was approximately 15%, indicating a substantial contribution of HIF-1alphaI.1 to total HIF-1alpha expression. The promoters of both isoforms were induced by LPS but not enhanced further by NECA, suggesting A(2A)R-mediated post-transcriptional regulation. LPS/NECA-induced expression of HIF-1alphaI.1 was down-regulated by Bay 11-7085 (NF-kappaB inhibitor) and ZM241385 (A(2A)R antagonist). Although VEGF and IL-10 expression by HIF-1alphaI.1-/- macrophages was equivalent to that of wild-type macrophages, TNF-alpha, MIP-1alpha, IL-6, IL-12p40, and IL-1beta expression was significantly greater, suggesting a role for HIF-1alphaI.1 in modulating expression of these cytokines. A(2A)R expression in unstimulated macrophages was low but was induced rapidly by LPS in a NF-kappaB-dependent manner. LPS-induced expression of A(2A)Rs and HIF-1alpha and A(2A)R-dependent HIF-1alpha mRNA and protein stabilization provide mechanisms for the synergistic effects of LPS and A(2A)R agonists on macrophage VEGF expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477908      PMCID: PMC2796622          DOI: 10.1189/jlb.0109021

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  47 in total

1.  Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia.

Authors:  S Salceda; I Beck; J Caro
Journal:  Arch Biochem Biophys       Date:  1996-10-15       Impact factor: 4.013

2.  Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension.

Authors:  B H Jiang; G L Semenza; C Bauer; H H Marti
Journal:  Am J Physiol       Date:  1996-10

3.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

Authors:  J A Forsythe; B H Jiang; N V Iyer; F Agani; S W Leung; R D Koos; G L Semenza
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha.

Authors:  R H Wenger; A Rolfs; H H Marti; J L Guénet; M Gassmann
Journal:  Biochem Biophys Res Commun       Date:  1996-06-05       Impact factor: 3.575

5.  The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells.

Authors:  S M Wood; J M Gleadle; C W Pugh; O Hankinson; P J Ratcliffe
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

6.  Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor.

Authors:  K Gradin; J McGuire; R H Wenger; I Kvietikova; M L fhitelaw; R Toftgård; L Tora; M Gassmann; L Poellinger
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 7.  Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation.

Authors:  Cormac T Taylor
Journal:  J Physiol       Date:  2008-07-03       Impact factor: 5.182

8.  Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

Authors:  A P Levy; N S Levy; S Wegner; M A Goldberg
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

9.  The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist.

Authors:  S M Poucher; J R Keddie; P Singh; S M Stoggall; P W Caulkett; G Jones; M G Coll
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

10.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.

Authors:  G Melillo; T Musso; A Sica; L S Taylor; G W Cox; L Varesio
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  25 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 2.  Regulation of macrophage function by adenosine.

Authors:  György Haskó; Pál Pacher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

Review 3.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

4.  Differential signal pathway activation and 5-HT function: the role of gut enterochromaffin cells as oxygen sensors.

Authors:  Martin Haugen; Rikard Dammen; Bernhard Svejda; Bjorn I Gustafsson; Roswitha Pfragner; Irvin Modlin; Mark Kidd
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-30       Impact factor: 4.052

5.  Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha.

Authors:  Alessio Paone; Roberta Galli; Chiara Gabellini; Dmitriy Lukashev; Donatella Starace; Agnes Gorlach; Paola De Cesaris; Elio Ziparo; Donatella Del Bufalo; Michail V Sitkovsky; Antonio Filippini; Anna Riccioli
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

6.  Hypoxia-inducible factor-1α enhances the malignant phenotype of multicellular spheroid HeLa cells in vitro.

Authors:  Xun Tian; Wei Wang; Qinghua Zhang; Liangping Zhao; Junchen Wei; Hui Xing; Yuping Song; Shixuan Wang; Ding Ma; Li Meng; Gang Chen
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

7.  Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model.

Authors:  Peter Georgiev; Bryan G Belikoff; Stephen Hatfield; Akio Ohta; Michail V Sitkovsky; Dmitriy Lukashev
Journal:  Eur J Immunol       Date:  2013-01-31       Impact factor: 5.532

8.  HIF-2α in Resting Macrophages Tempers Mitochondrial Reactive Oxygen Species To Selectively Repress MARCO-Dependent Phagocytosis.

Authors:  Shirley Dehn; Matthew DeBerge; Xin-Yi Yeap; Laurent Yvan-Charvet; Deyu Fang; Holger K Eltzschig; Stephen D Miller; Edward B Thorp
Journal:  J Immunol       Date:  2016-09-26       Impact factor: 5.422

9.  Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype.

Authors:  Stan Grinberg; Gyorgy Hasko; Dianqing Wu; Samuel Joseph Leibovich
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

Review 10.  Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy.

Authors:  Stephen M Hatfield; Michail V Sitkovsky
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.